Clinical Trials

4 enrolled 6 charts

Bile Duct Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT00006089 2019-07-31

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

34 enrolled

Gynecologic

Endometrial Adenocarcinoma

NCT01688609 2017-09-11

Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer

18 enrolled 7 charts

Breast Neoplasms

NCT00079326 2014-06-02

Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer

39 enrolled 8 charts

Breast Neoplasms

NCT00077376 2014-05-21

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

61 enrolled 12 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00003797 2013-12-19

Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas

Phase 2 Unknown

41 enrolled

Pancreatic Neoplasms

NCT00006228 2013-10-08

Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

37 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2 Unknown

160 enrolled

Breast Neoplasms

NCT00107393 2013-07-10

Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer

75 enrolled

Breast Neoplasms

NCT00104949 2013-06-24

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

40 enrolled

Sarcoma

Sarcoma, Sarcoma, Synovial

NCT00003881 2013-06-21

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00005033 2013-06-21

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

Sarcoma

Sarcoma, Osteosarcoma

NCT00003992 2013-06-03

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

200 enrolled

Breast Neoplasms

NCT00006015 2013-05-03

Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer

26 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00126607 2013-02-28

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

35 enrolled

Head & Neck

Salivary Gland Neoplasms

NCT00003995 2013-02-08

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2

32 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00023998 2013-02-04

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

80 enrolled

Sarcoma

Osteosarcoma

NCT00005831 2013-01-14

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer

40 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00019812 2012-03-23

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2

55 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00301899 2012-03-08

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

37 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005926 2008-03-04

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

50 enrolled